---
title: "Crystal Tai × Deep Principle: Deepening Supramolecular Materials Cooperation with Shanhai Innovation"
type: "Topics"
locale: "en"
url: "https://longbridge.com/en/topics/40202066.md"
description: "I. Key Events • On April 23, 2026, Deep Principle and Shanhai Innovation announced the deepening of their strategic cooperation. The two parties will jointly promote the application of AI for Materials technology in the R&D of high-value new skincare molecules; • Deep Principle provides generative AI technology (LLM+Diffusion models, Agent Mira and other material agents) for molecular design, performance prediction, synthesis pathway planning, and microscopic mechanism analysis; • Shanhai Innovation provides industry application scenarios, experimental validation, and industrialization resources..."
datetime: "2026-04-26T02:20:16.000Z"
locales:
  - [en](https://longbridge.com/en/topics/40202066.md)
  - [zh-CN](https://longbridge.com/zh-CN/topics/40202066.md)
  - [zh-HK](https://longbridge.com/zh-HK/topics/40202066.md)
author: "[周树人的交易员](https://longbridge.com/en/profiles/12816038.md)"
---

# Crystal Tai × Deep Principle: Deepening Supramolecular Materials Cooperation with Shanhai Innovation

I. Key Events  
• On April 23, 2026, Deep Principle and Shanhai Innovation announced a deepened strategic partnership. The two parties will jointly promote the application of AI for Materials technology in the R&D of high-value new skincare molecules;  
• Deep Principle provides generative AI technology (including LLM+Diffusion models, Agent Mira and other material agents) for molecular design, performance prediction, synthesis pathway planning, and micro-mechanism analysis;  
• Shanhai Innovation provides industry application scenarios, experimental validation, and industrialization resources, focusing on the rapid discovery and development of high-value skincare active ingredients (such as new functional molecules, supramolecular materials, etc.).

II. Goals and Significance  
• Goal: To accelerate the entire process from AI design to the commercial application of actual skincare ingredients, creating a new AI-driven paradigm for new molecule R&D in skincare;  
• Significance: This is another important commercial application case of AI for Materials technology in the consumer goods/daily chemical sector, marking the deepening of Deep Principle's AI platform from general technology to specific high-value industry applications, helping the skincare industry achieve "faster, more precise, and more innovative" new molecule R&D.

III. Shanhai Innovation  
• Primarily B2B, it is a cosmetic ingredient supplier specializing in supramolecular modified raw materials (such as supramolecular salicylic acid, supramolecular carnosine, supramolecular copper peptide, supramolecular retinol, etc.);  
• Its clients are mainly cosmetic brands, formulation factories, and OEM/ODM manufacturers. These companies purchase Shanhai's ingredients, add them to their own finished products like skincare items, masks, and serums, and then sell them to end consumers;  
• As a non-listed company (having completed multiple rounds of financing, with Series C nearing 100 million yuan and a valuation of approximately 3 billion yuan), it is currently in the early commercialization stage of rapid growth. It has real orders (including joint development projects with L'Oréal, etc.), but its overall scale still belongs to a medium-sized innovative enterprise in a niche field, far smaller than comprehensive ingredient leaders like Bloomage Biotech.

IV. History of Cooperation between Deep Principle and Shanhai Innovation  
• March 2025: Shanhai Innovation and Deep Principle jointly built the world's first AI supramolecular material synthesis matrix (the "Synthrix® / Synthrix™ 1.0" platform), officially launching it;  
• Around October 2025: Version 1.0 of this platform was operational, and the two parties had achieved phased commercial progress in AI-driven supramolecular material R&D (including high-throughput screening, molecular design, etc.);  
• April 23, 2026: The two parties formally signed a joint pipeline co-research and commercialization framework agreement, launching joint pipeline R&D around multiple high-value skincare active ingredients (e.g., anti-aging, antioxidant, whitening, soothing, etc.). They also expanded the scope of cooperation to areas like new energy and advanced industrial manufacturing materials, exploring composite business models from project implementation to long-term industrial benefits.

Thought Record: This cooperation essentially involves creating a supramolecular nutrient delivery system to better "deliver" active ingredients to the skin or target locations, improving stability and efficacy. For Jingtai, this further validates Deep Principle's commercial potential in non-pharmaceutical new materials (especially supramolecular/daily chemical) and continues to deepen its ecosystem layout and equity value.

$XTALPI(02228.HK)

### Related Stocks

- [02228.HK](https://longbridge.com/en/quote/02228.HK.md)
- [688363.CN](https://longbridge.com/en/quote/688363.CN.md)
- [LRLCY.US](https://longbridge.com/en/quote/LRLCY.US.md)